The global U.S. compounding pharmacies market size is expected to reach around US$ 5069.56 million by 2027 from US$ 3450.42 million in 2021 and is expected to grow at an impressive double-digit rate of 6.5% from 2022 to 2027.
The study includes drivers and restraints of this market. The study provides an analysis of the global U.S. compounding pharmacies market for the period 2017-2027, wherein 2022 to 2027 is the forecast period and 2021 is considered as the base year.
- By product, the oral medications segment accounted for 51% while the parenteral medication segment garnered a market share of 18% respectively, in 2021
- By pharmacy type, the 503A segment is expected to grow at a CAGR of 2.3% from 2022 to 2030
- By sterility, the non-sterile segment accounted for 62.5% of the US compounding pharmacies market share in 2020
- Approximately 1,806,590 new cancer cases were estimated to be diagnosed in US in 2020
- Around 606,520 cancer deaths were estimated in US in 2020
- The cancer incidence or rate of new cancer cases in men is 442.4 per 100,000 per year in US
- The cancer death rate is 158.3 per 100,000 per year in US
- Around 16,850 adolescents and children aged 0 to 19 years would be diagnosed with cancer in US in 2020
- US$ 150.8 billion was estimated to be the national cancer care expenditure in US in 2018
- Around 24% of the total US population will be geriatric by 2060
- The lungs, prostate, and colorectal cancer collectively accounted for 43% of the total new cancer cases diagnosed in men in 2021
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 180+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1662
Report Scope of the U.S. Compounding Pharmacies Market
| Report Coverage | Details |
| Market Size by 2027 | USD 5069.56 Million |
| Growth Rate from 2020 to 2027 | CAGR of 6.5% |
| Non-sterile Segment Market Share in 2021 | 62.5% |
| Oral Medications Segment Market Share in 2021 | 51% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
What are the key trends in the US Compounding Pharmacies Market?
The rising investments in the research and development and the increased efforts of the market players to innovate their products is expected to boost the growth of the compounding pharmacies market in US. The development of oral liquids, gummy treats, topical gels, and effervescent drinks for the children or pediatric population is driving the demand for the compounding pharmacies significantly. Moreover, the increasing popularity of the pain management therapies in US is bolstering the growth of the US compounding pharmacies market. Most of the compounded pain management drugs are not approved by the US FDA. However, the State Pharmacy Board controls and supervises on this. Furthermore, the demand for the hormone replacement therapy drugs is growing significantly with the surging prevalence of breast cancer among the women population in US. The growing geriatric population and increased penetration of the social media platforms in US is significantly boosting the adoption of the hormone replacement therapy drugs.
What are the key challenges in the US Compounding Pharmacies Market?
As there is a lack of standard regulatory norms regarding the compounded drugs in US, safety is a major issue faced by the market players. The Food and Drug Administration does not regulate the compounded drugs and hence there is a lack of proper standardization. The lack of consumer confidence due to it may hamper or restrict the growth of the US compounding pharmacies market in the upcoming future. Moreover, the changing regulatory specifications are another major challenge faced by the market players operating in the US compounding pharmacies market.
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global U.S. compounding pharmacies market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global U.S. compounding pharmacies market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global U.S. compounding pharmacies market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for U.S. compounding pharmacies are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2027, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global U.S. compounding pharmacies market include:
- Triangle compounding pharmacy
- Fagron
- B. Braun melsungen ag
- Fresenius kabi ag
- Pencol Compounding Pharmacy
- US Compounding Inc.
- Avella specialty pharmacy
- Institutional pharmacy solutions, llc
- Pharmedium services llc
- Vertisis custom pharmacy
Market Segmentation:
By Pharmacy Type
- 503A
- 503B
By Product
- Oral
- Capsules
- Granules
- Tablets
- Powder
- Others
- Liquid Preparations
- Emulsion
- Syrup
- Solutions
- Suspension
- Others
- Topical
- Gels
- Ointments
- Creams
- Pastes
- Others
- Rectal
- Enema
- Suppositories
- Others
- Parenteral
- SVP
- LVP
- Ophthalmic
- Nasal
- Otic
By Sterility
- Sterile
- Non-Sterile
By Application
- Adult
- Geriatric
- Pediatric
- Veterinary
By Compounding Type
- Pharmaceutical Ingredient Alteration (PIA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Others
By Therapeutic Area
- Hormone replacement
- Pain management
- Dermatology
- Specialty drugs
- Nutritional supplements
- Others
Key Questions Answered by the Report:
- What will be the size of the global U.S. compounding pharmacies market in 2027?
- What is the expected CAGR for the U.S. compounding pharmacies market between 2021 and 2027?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global U.S. compounding pharmacies market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Therapeutic Area Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Compounding Pharmacies Market
5.1. COVID-19 Landscape: Compounding Pharmacies Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: U.S. Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Compounding Pharmacies Market, By Pharmacy Type
8.1. Compounding Pharmacies Market, by Pharmacy Type, 2022-2030
8.1.1. 503A
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. 503B
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. U.S. Compounding Pharmacies Market, By Product Type
9.1. Compounding Pharmacies Market, by Product Type, 2022-2030
9.1.1. Oral
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Liquid Preparations
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Topical
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Rectal
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Otic
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Nasal
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Ophthalmic
9.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 10. U.S. Compounding Pharmacies Market, By Sterility Type
10.1. Compounding Pharmacies Market, by Sterility Type, 2022-2030
10.1.1. Sterile
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Non-Sterile
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. U.S. Compounding Pharmacies Market, By Application Type
11.1. Compounding Pharmacies Market, by Application Type, 2022-2030
11.1.1. Adult
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Geriatric
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Pediatric
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Veterinary
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. U.S. Compounding Pharmacies Market, By Compounding
12.1. Compounding Pharmacies Market, by Compounding, 2022-2030
12.1.1. Pharmaceutical Ingredient Alteration (PIA)
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Pharmaceutical Dosage Alteration (PDA)
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 13. U.S. Compounding Pharmacies Market, By Therapeutic Area
13.1. Compounding Pharmacies Market, by Product Type, 2022-2030
13.1.1. Hormone replacement
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Pain management
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Dermatology
13.1.3.1. Market Revenue and Forecast (2017-2030)
13.1.4. Specialty drugs
13.1.4.1. Market Revenue and Forecast (2017-2030)
13.1.5. Nutritional supplements
13.1.5.1. Market Revenue and Forecast (2017-2030)
13.1.6. Others
13.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 14. U.S. Compounding Pharmacies Market, Regional Estimates and Trend Forecast
14.1. U.S.
14.1.1. Market Revenue and Forecast, by Pharmacy (2017-2030)
14.1.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.3. Market Revenue and Forecast, by Sterility (2017-2030)
14.1.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.5. Market Revenue and Forecast, by Compounding (2017-2030)
14.1.6. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
Chapter 15. Company Profiles
15.1. Triangle compounding pharmacy
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Fagron
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. B. Braun melsungen ag
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Fresenius kabi ag
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Pencol Compounding Pharmacy
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. US Compounding Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Avella specialty pharmacy
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Institutional pharmacy solutions, llc
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Pharmedium services llc
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Vertisis custom pharmacy
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1662
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://precedenceresearchnews.wordpress.com
0 Comments